Concepedia

N. Sandrenan

NS

Statistics

Publications

5

Citations

240

H-Index

5

Active since

1983

Affiliations

Novartis (Switzerland)(Current)

N. Sandrenan is an author at Novartis (Switzerland) specializing in pharmacy, pharmacology, and analytical chemistry.

Publications per year

1983–2002

5

Publications

5

Development and validation of a high-performance liquid chromatography–mass spectrometry assay for the determination of artemether and its metabolite dihydroartemisinin in human plasma

C. Souppart, N. Gauducheau, N. Sandrenan et al. · Journal of Chromatography B · 2002 · 85 citations

Pharmacy, Pharmacology, Toxicology +13

COMPARATIVE BIOAVAILABILITY OF LETROZOLE UNDER FED AND FASTING CONDITIONS IN 12 HEALTHY SUBJECTS AFTER A 2·5 MG SINGLE ORAL ADMINISTRATION

A. Sioufi, N. Sandrenan, J. Godbillon et al. · Biopharmaceutics & Drug Disposition · 1997 · 77 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Determination of artemether and its metabolite, dihydroartemisinin, in plasma by high-performance liquid chromatography and electrochemical detection in the reductive mode

N. Sandrenan, A. Sioufi, J. Godbillon et al. · Journal of Chromatography B Biomedical Sciences and Applications · 1997 · 43 citations

Pharmacy, Pharmacology, Toxicology +16

Gas chromatographic determination of metoprolol in human plasma

A. Sioufi, Frederique Leroux, N. Sandrenan · Journal of Chromatography B Biomedical Sciences and Applications · 1983 · 20 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

High performance liquid chromatographic determination of nicotine and cotinine in plasma and nicotine and cotinine, simultaneously, in urine.

A. Sioufi, C Parisot, N. Sandrenan et al. · PubMed · 1989 · 15 citations

Pharmacy, Pharmacokinetics, Toxicology +13

1–5 of 5